|
|
Ulcerative Colitis and the Role of S1P Receptor Modulators and JAK Inhibitors " A Wheel of Knowledge Challenge!
Ulcerative colitis (UC), a type of inflammatory bowel disease, is a chronic relapsing condition characterized by an overly active immune response in the large intestine, resulting in inflammation and ulceration. Given the increasing prevalence of disease and rapid influx of available biologics and small molecule therapies, there is great need for ongoing education regarding new and emerging treatment approaches for the management of UC. In this continuing education program, expert clinicians w... |
|
|
Addressing Key Questions About BCMA-Targeted Therapy for Relapsed/Refractory Multiple Myeloma
ACTIVITY DESCRIPTION
Though treatment advances have improved outcomes for most patients, MM remains an incurable disease characterized by continuous relapse. However, the treatment landscape for relapsed/refractory MM (RRMM) has expanded in recent years, and patients who relapse and/or become refractory to initial therapies are benefiting from the increasing availability of a diverse range of novel agents, including B-cell maturation antigen (BCMA)"targeted immunotherapies. These agents ... |
|
|
Navigating Novel Terrain in Vitiligo Management: A Practical, Patient-Centric Review
Target Audience
This educational activity is targeted to Advanced Practice Providers (APPs) " Physician Assistants and Nurse Practitioners " who practice in community settings.
Program Overview
This online activity will provide Advanced Practice Providers (APPs) " Physician Assistants and Nurse Practitioners " with a comprehensive overview of vitiligo, emphasizing pathogenic mechanisms, patient burden, and emerging treatment approaches.
Learning Objectives
Upon com... |
|